08/04/2025
8:00 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2025
6:24 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2025
4:27 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2025
11:15 PM | Mangoceuticals (Filer)
| Form EFFECT | |
06/19/2025
11:15 PM | Mangoceuticals (Filer)
| Form EFFECT | |
05/23/2025
4:27 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
8:00 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2025
4:00 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
4:00 PM | Mangoceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/28/2025
4:00 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
8:00 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MGRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Mangoceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/20/2025
4:29 PM | Mangoceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/19/2025
8:00 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2025
8:00 AM | Mangoceuticals (Filer)
| Form DEF 14A | |
02/12/2025
7:00 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
4:25 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
3:46 PM | Mangoceuticals (Filer)
| Form PRE 14A | |
01/31/2025
4:25 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2025
4:28 PM | GREENFIELD INVESTMENTS LTD. (Filed by)
Mangoceuticals (Subject)
| Form SCHEDULE 13G | |
01/21/2025
3:30 PM | Isaac Antonios (Reporting)
Mangoceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/21/2025
3:30 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2025
3:30 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
3:30 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2024
3:30 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
4:30 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
4:15 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
4:04 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
4:06 PM | JOHNSTON EUGENE M (Reporting)
Mangoceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
7:00 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
4:00 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
7:00 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
4:10 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
4:15 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
7:30 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
4:25 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
6:30 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:30 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
11:15 PM | Mangoceuticals (Filer)
| Form EFFECT | |
08/30/2024
4:25 PM | Mangoceuticals (Filer)
| Form AW | |
08/27/2024
6:45 PM | Cohen Jacob D. (Filed by)
Mangoceuticals (Subject)
| Form SC 13D/A | |
08/27/2024
6:41 PM | Cohen Jacob D. (Reporting)
Mangoceuticals (Issuer)
Tiger Cub Trust (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s national nightmare is here (Ad) Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II.
They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes. Watch the National Emergency broadcast here |
08/23/2024
3:41 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
8:25 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
4:15 PM | Mangoceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
MarketBeat All Access